I am a clinician-researcher working in oncogenomics, lung cancer, precision oncology, and the use of artificial intelligence to predict treatment response and guide personalized cancer therapy. I completed GCSRT program at Harvard in 2025 with Distinction, and my capstone proposal recognized among the Top 10. I am currently pursuing the Master of Medical Sciences in Clinical Investigation (MMSCI) at Harvard Medical School and a Graduate Researcher at Dana Farber Cancer Institute